Medtronic, Inc. Receives CE Mark for Export Advance Aspiration Catheter
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Expanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic (NYSE: MDT [FREE Stock Trend Analysis]) announced today that the Export Advance aspiration catheter recently received the CE (Conformité Européenne) mark and will soon be launched in Europe and other international markets. The new thrombus removal system from the market leader in the product category offers superior deliverability en route to the aspiration site. The Export Advance aspiration catheter is not approved for use in the United States. The latest addition to the Export family of aspiration catheters will be on exhibit during EuroPCR (May 21-24 in Paris) at the Medtronic booth.
Help employers find you! Check out all the jobs and post your resume.
Expanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic (NYSE: MDT [FREE Stock Trend Analysis]) announced today that the Export Advance aspiration catheter recently received the CE (Conformité Européenne) mark and will soon be launched in Europe and other international markets. The new thrombus removal system from the market leader in the product category offers superior deliverability en route to the aspiration site. The Export Advance aspiration catheter is not approved for use in the United States. The latest addition to the Export family of aspiration catheters will be on exhibit during EuroPCR (May 21-24 in Paris) at the Medtronic booth.
Help employers find you! Check out all the jobs and post your resume.